Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on September 4, 2025
Silent Killer: HTLV 2026 Conference Launches Global Campaign to Fight HIV’s “Cousin” Virus Infecting Millions
Philadelphia, PA , Sept. 04, 2025 (GLOBE NEWSWIRE) -- HTLV 2026, the international conference dedicated to advance discovery research on Human T-cell Leukemia Virus Type 1 (HTLV-1), today announced the launch of a global awareness campaign to combat the …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Praxis Precision Medicines to Participate in September Investor Conferences
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Indaptus Therapeutics Provides Clinical Update
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
Inventiva to Participate in Upcoming September Investor Conferences
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone. Covering five rare disease eligible indications, the accessible market in the US could be as high as 40,000 patients. Focused on improved …
What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era
DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Institutions, and organizations across the life sciences continuum are seeking clarity on how federal research and development (R…
Rise of Weed Pollen and Return to School Ushers in Sneezing Season
Washington, DC, Sept. 04, 2025 (GLOBE NEWSWIRE) -- If you’re sneezing this season, the reason could be a respiratory infection or weed pollen allergy. A review of pollen counts from cities across the country reveals a rise in levels of ragweed pollen as …
ProductLife Group expandiert nach Japan und bietet lokales Fachwissen sowie verbesserten Kundensupport
PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Die ProductLife Group (PLG) freut sich, die Eröffnung ihrer neuesten Niederlassung in Japan bekannt zu geben und damit ihr Engagement für die Erfüllung der sich wandelnden Kundenbedürfnisse und Marktanforderungen …
ProductLife Group s’agrandit pour offrir une expertise localisée et un service client amélioré au Japon
PARIS, 04 sept. 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) est fier d’annoncer l’ouverture de son tout nouveau bureau au Japon, venant réaffirmer son engagement à répondre aux besoins changeants de ses clients et aux exigences du marché. Cet …
ProductLife Group Memperluas Layanan untuk Keahlian Lokal & Dukungan Klien yang Lebih Baik di Jepang
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangga mengumumkan pembukaan kantor barunya di Jepang, menguatkan komitmennya untuk memenuhi kebutuhan klien dan tuntutan pasar yang terus berkembang. Ekspansi ini meningkatkan …
ProductLife Group, 일본에 진출하며 현지 전문성 강화 및 고객 지원 확대
파리, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG)이 일본에 신규 사무소를 개소하게 되었다고 발표했다. 이번 확장은 변화하는 고객의 니즈와 시장 수요에 부응하겠다는 PLG의 의지를 강화하는 한편, 역량을 확대하고 지역 및 글로벌 네트워크를 강화하며, 추가 시장과 서비스 지원을 위한 원활한 협업을 가능하게 한다는 취지로 평가된다. 생명과학 기업들이 전 세계적 전문성과 현지 인재를 점점 더 필요로 …
ProductLife Group Mengembangkan Operasi untuk Menyampaikan Kepakaran Setempat dan Sokongan Klien yang Dipertingkatkan di Jepun
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangganya mengumumkan pembukaan pejabat terbaharu di Jepun, sekali gus memperkukuh komitmennya untuk memenuhi keperluan klien yang semakin berkembang serta tuntutan pasaran yang …
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ …